The results of Kaplan-Meier survival analysis revealed that ccRCC patients whose tumors expressed higher nuclear levels of nuclear SMAD4 showed significantly poorer DSS than those other phenotypes expressions (P = 0.013) (Figure 2B and Supplementary Table S4). Here, SMAD4 is linked to nonpapillary renal cell carcinoma.